You are here
Home 🌿 Medical Cannabis News 🌿 New Study Finds Hemp Oil Can Help Treat Chronic Neuropathic Pain 🌿New Study Finds Hemp Oil Can Help Treat Chronic Neuropathic Pain

It’s another step towards lessening our dependency on the pharmacological use of opioids and opioid-derivatives.
Medical professionals and researchers throughout the U.S. are seeking to steer patients away from opioids and other severely addictive medications. The University of New Mexico released a study in May, published in the scientific journal Life, with positive long-term results in the expanded use of hemp oil to treat chronic neuropathic pain.
Researchers seek to rely on increasingly natural and organic ways to treat chronic pain. The biggest takeaway from this UNM study is the increased efficacy of hemp oil, which means an opportunity to move away from dependence on the pharmacological use of opioids and opioid-derivatives.
Conventional pharmacological drugs are ranking high as one of the leading forms of causing preventable deaths, and conventional medical errors are the third leading cause of death in the U.S..
“Cannabis plants with low THC are still psychoactive, but tend to result in less psychedelic experiences, while still offering profound and often immediate relief from symptoms such as pain, anxiety, and depression,” says co-researcher Dr. Jacob Miguel Vigil, an associate professor in the UNM Psychology Department.
The UNM researchers used mice as a study subject to examine both the efficacy and the safety of cannabis products. For several hours after being dosed with hemp oil, the mice demonstrated reduced pain. Cannabis oils have been used to relieve aches and pains, anxiety, sleep disturbances and other maladies. They’re also widely available in your local drug store, big box retailer and Amazon. (Just make sure your product is legit before purchasing.)
Cannabis plants can also produce cannabinoid (CBD). If your CBD oil is purified from hemp plants (hemp CBD), it’s federally legal. If not, it’s still illegal on a federal level, classified as a Schedule 1 drug.
Farmers harvest the plant and collect CBD. But caution is strongly advised because the extraction process for THC is essentially the same as CBD, which means the CBD you just bought likely contains a bit of THC.
Photo by ColiN00B via Pixabay
“There are many intriguing findings in pre-clinical studies that suggest CBD and hemp oil have anti-inflammatory effects and may be helpful with improving sleep and anxiety,” says Dr. Brent Bauer, an internist and director of research for the Mayo Clinic Integrative Medicine program. Dr. Bauer cautioned in 2019 that the studies on humans are still relatively limited.
There is still the need for additional information and continued study in the use of cannabis oils to alleviate pain. In addition to medical professionals, this is still an evolving area to keep up on the latest information for patients, medical professionals, retailers, law enforcement professionals, city and state officials, among others.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.